Works about BELIMUMAB
Results: 290
Efficacy and safety of belimumab in primary sjögren's syndrome: results of the BELISS open-label Phase II study.
- Published in:
- Current Medical Literature: Rheumatology, 2014, v. 33, n. 1, p. 31
- By:
- Publication type:
- Article
Effect of belimumab treatment on renal outcomes: results from the Phase 3 belimumab clinical trials in patients with SLE.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 23
- By:
- Publication type:
- Article
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two Phase III trials.
- Published in:
- Current Medical Literature: Rheumatology, 2013, v. 32, n. 1, p. 22
- By:
- Publication type:
- Article
Effectiveness and safety of Belimumab and Telitacicept in systemic lupus erythematosus: a real-world, retrospective, observational study.
- Published in:
- Clinical Rheumatology, 2025, v. 44, n. 1, p. 247, doi. 10.1007/s10067-024-07266-y
- By:
- Publication type:
- Article
Effects of belimumab on the lipid profile in systemic lupus erythematosus patients: an observational study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 8, p. 2513, doi. 10.1007/s10067-024-07029-9
- By:
- Publication type:
- Article
Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 3, p. 1023, doi. 10.1007/s10067-024-06904-9
- By:
- Publication type:
- Article
Response to belimumab among patients with refractory lupus nephritis: a real-world observational retrospective multicenter study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 199, doi. 10.1007/s10067-023-06817-z
- By:
- Publication type:
- Article
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 11, p. 3083, doi. 10.1007/s10067-023-06635-3
- By:
- Publication type:
- Article
Role of ultrasound and magnetic resonance imaging in systemic lupus erythematosus erosive arthritis treatment response prediction. Correspondence on: "Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus"
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2525, doi. 10.1007/s10067-023-06669-7
- By:
- Publication type:
- Article
Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 12, p. 3735, doi. 10.1007/s10067-022-06325-6
- By:
- Publication type:
- Article
Use of belimumab in real-world in Spain: a scoping review about characteristics of SLE patients.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 11, p. 3373, doi. 10.1007/s10067-022-06287-9
- By:
- Publication type:
- Article
Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Potential and prognostic factor for belimumab-free remission in patients with systemic lupus erythematosus: a single-center retrospective analysis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 12, p. 3653, doi. 10.1007/s10067-020-05052-0
- By:
- Publication type:
- Article
Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18028
- By:
- Publication type:
- Article
Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy.
- Published in:
- Frontiers in Immunology, 2013, v. 4, p. 1, doi. 10.3389/fimmu.2013.00494
- By:
- Publication type:
- Article
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Iris Heterochromia and Unilateral Eyelash Hypertrichosis.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus : A Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Biologics in systemic lupus erythematosus: current options and future perspectives.
- Published in:
- British Journal of Hospital Medicine (17508460), 2014, v. 75, n. 8, p. 440, doi. 10.12968/hmed.2014.75.8.440
- By:
- Publication type:
- Article
New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 2, p. 584, doi. 10.3390/jcm14020584
- By:
- Publication type:
- Article
Real-World Effectiveness of Belimumab in Patients with Active Lupus.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 24, p. 7627, doi. 10.3390/jcm12247627
- By:
- Publication type:
- Article
Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1083, doi. 10.3390/jcm12031083
- By:
- Publication type:
- Article
Effectiveness and Safety of Belimumab in Chinese Lupus Patients: A Multicenter, Real-World Observational Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 962, doi. 10.3390/biomedicines11030962
- By:
- Publication type:
- Article
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS).
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 691, doi. 10.3390/jpm13040691
- By:
- Publication type:
- Article
Current and emerging treatment options in the management of lupus.
- Published in:
- ImmunoTargets & Therapy, 2016, v. 5, p. 9, doi. 10.2147/ITT.S40675
- By:
- Publication type:
- Article
Terapie biologiczne w toczniu rumieniowatym układowym.
- Published in:
- Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2012, v. 66, p. 568
- By:
- Publication type:
- Article
Improvement in Cutaneous Lupus Erythematosus After 20 Weeks of Belimumab Use - A Systematic Review and Meta-Analysis.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 8, p. 1838, doi. 10.1002/acr.25058
- By:
- Publication type:
- Article
Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 2, p. 187, doi. 10.1002/acr.24431
- By:
- Publication type:
- Article
Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 2, p. 262, doi. 10.3390/cells11020262
- By:
- Publication type:
- Article
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1074044
- By:
- Publication type:
- Article
Effectiveness and safety of Belimumab combined with standard therapy in severe active lupus nephritis requiring kidney replacement therapy: A case report and literature review.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.977377
- By:
- Publication type:
- Article
Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.980079
- By:
- Publication type:
- Article
Belimumab in childhood systemic lupus erythematosus: A review of available data.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.940416
- By:
- Publication type:
- Article
Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.962088
- By:
- Publication type:
- Article
Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.777502
- By:
- Publication type:
- Article
A Rare Case of Prototheca Algaemia in a Patient with Systemic Lupus Erythematosus and Recent Belimumab Infusion.
- Published in:
- Case Reports in Immunology, 2012, p. 1, doi. 10.1155/2012/754901
- By:
- Publication type:
- Article
Does Belimumab Reduce Disease Activity in Adults with Systemic Lupus Erythematosus?
- Published in:
- Clinical Medicine Reviews in Therapeutics, 2012, v. 4, p. 71, doi. 10.4137/CMRT.S6575
- By:
- Publication type:
- Article
Doporučení EULAR 2023 pro nefarmakologickou léčbu systémového lupus erythematodes a systémové sklerodermie.
- Published in:
- Czech Rheumatology / Česká Revmatologie, 2024, v. 32, n. 2, p. 82
- By:
- Publication type:
- Article
Doporučení ČRS pro léčbu nemocných se SLE.
- Published in:
- Czech Rheumatology / Česká Revmatologie, 2013, v. 21, n. 3, p. 110
- By:
- Publication type:
- Article
CASE STUDY: 67-year-old Caucasian man who desires glaucoma medication reduction.
- Published in:
- Ocular Surgery News, 2018, p. 10
- By:
- Publication type:
- Article
Drug delivery devicesmay be future of glaucoma therapy.
- Published in:
- Ocular Surgery News, 2017, p. 13
- By:
- Publication type:
- Article
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. e1198, doi. 10.1111/jdv.19184
- By:
- Publication type:
- Article
A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 8, p. e330, doi. 10.1111/jdv.14882
- By:
- Publication type:
- Article
Belimumab in Systemic Lupus Erythematosus.
- Published in:
- Indian Journal of Dermatology, 2016, v. 61, n. 5, p. 550, doi. 10.4103/0019-5154.190107
- By:
- Publication type:
- Article
New drugs and dosage forms.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 17, p. 1296
- Publication type:
- Article
A case report of systemic lupus erythematosus presented as thrombotic thrombocytopenic purpura and successfully treated with plasmapheresis and belimumab.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 4, p. 856, doi. 10.1111/1744-9987.13807
- By:
- Publication type:
- Article
Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3011, doi. 10.1007/s10238-023-01132-y
- By:
- Publication type:
- Article
Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis.
- Published in:
- Rheumatology Advances in Practice, 2021, v. 5, n. 1, p. 1, doi. 10.1093/rap/rkab023
- By:
- Publication type:
- Article